• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 309/08 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 309/08

Total number of patents in this class: 227

10-year publication summary

16
14
16
21
11
13
13
22
10
9
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Corsair Pharma, Inc.
37
13
Bristol-myers Squibb Company
4867
11
The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin
165
7
The University of Queensland
663
7
The General Hospital Corporation
4759
6
The Broad Institute, Inc.
1837
6
Enanta Pharmaceuticals, Inc.
429
6
Global Blood Therapeutics, Inc.
183
6
Massachusetts Institute of Technology
10102
5
Theravance Biopharma R&D IP, LLC
456
5
Xwpharma Ltd.
58
5
Abbvie Inc.
1800
4
Takeda Pharmaceutical Company Limited
2705
4
Cytokinetics, Inc.
280
4
Dongjin Semichem Co., Ltd.
486
4
Modernatx, Inc.
1284
4
Temple University of the Commonwealth System of Higher Education
626
4
Praeventix, LLC
14
4
Orsobio, Inc.
13
4
BASF SE
20979
3
Other owners 115